Gene editing

Health
CRISPR in 2026: Why We Are Finally Curing the 'Incurable'
CRISPR is now an approved therapy for sickle cell disease and beta thalassemia, with cholesterol trials underway. Cost, safety and germline ethics remain hurdles.
24 Jul, 2026·3 mins read